Cargando…
Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date
Potassium-competitive acid blocker (P-CAB) is a class of drug that competitively blocks the potassium-binding site of H(+), K(+)-adenosine triphosphate (ATP)ase. Although the history of this class of drugs started over 30 years ago, clinical use of two P-CABs, revaprazan and vonoprazan, were only re...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784563/ https://www.ncbi.nlm.nih.gov/pubmed/29383028 http://dx.doi.org/10.1177/1756283X17745776 |